	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	1,062	1,059	1,182	1,294	1,332	1,420	1,803	2,088	2,191	1,637	2,498	2,553	1,566	2,080	2,174	2,103
Cost of Operating Revenue	823	796	902	982	934	1,032	1,172	1,286	1,504	1,111	1,789	1,700	1,349	1,650	1,715	1,357
Gross Profit	239	263	280	312	399	387	632	802	688	526	710	852	218	430	459	746
Gross Margin	22.5	24.8	23.7	24.1	29.9	27.3	35.0	38.4	31.4	32.1	28.4	33.4	13.9	20.7	21.1	35.5
Total Operating Expenses	969	941	1,084	1,162	1,140	1,221	1,463	1,637	1,844	1,404	2,182	2,288	1,678	2,044	2,115	2,015
Operating Profit	94	118	97	132	193	198	340	451	347	233	317	264	-112	36	59	88
Operating Margin	8.8	11.1	8.2	10.2	14.5	14.0	18.9	21.6	15.8	14.2	12.7	10.4	-7.1	1.7	2.7	4.2
Financing Income/(Expense) - Net	61	-70	-34	-57	-38	-43	-16	-26	3	0	57	49	-15	-29	-7	-75
Profit before Taxes	23	58	54	60	146	156	326	409	359	252	409	313	-121	9	62	105
Income Taxes	19	30	18	14	35	40	88	113	70	65	104	75	-15	20	33	40
Profit after Tax	3	17	23	44	83	88	171	251	240	186	304	238	-106	-11	29	64
PAT Margin	0.3	1.6	1.9	3.4	6.2	6.2	9.5	12.0	11.0	11.4	12.2	9.3	-6.8	-0.5	1.3	3.1
EPS - Basic - ex Extraordinary Items	0.14	0.68	0.90	1.73	3.24	3.45	6.74	9.88	9.44	7.33	11.97	9.35	-4.17	-0.42	1.13	2.54
EPS - Diluted - ex Extraordinary Items	0.14	0.68	0.90	1.73	3.24	3.45	6.74	9.88	9.44	7.33	11.97	9.35	-4.17	-0.42	1.13	2.54
EBIT	94	118	97	132	193	198	340	451	347	233	317	264	-112	36	59	88
EBITDA	169	193	178	207	269	289	435	548	436	283	379	342	-19	144	178	207
EBITDA Margin	15.9	18.3	15.1	16.0	20.2	20.3	24.1	26.3	19.9	17.3	15.2	13.4	-1.2	6.9	8.2	9.9

Balance Sheet

Abridged

Understanding Balance Sheet

Meghmani Organics Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31
	R 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	IR	AR	AR	AR	AR
Total Current Assets	704	687	782	699	746	740	839	1,071	977	995	1,436	1,466	1,212	1,350	1,315
Long-Term Investments	1	1	1	7	1	1	1	1	1	202	225	153	98	3	4
Property Plant & Equipment - Net	725	778	801	791	808	779	854	1,238	1,694	735	1,088	1,510	1,659	1,640	1,562
Total Non-Current Assets	801	853	881	843	848	845	979	1,305	1,760	979	1,362	1,733	1,827	1,735	1,705
Total Assets	1,505	1,540	1,663	1,542	1,594	1,585	1,818	2,377	2,737	1,974	2,798	3,198	3,039	3,085	3,021
Total Current Liabilities	411	486	596	531	588	552	452	707	806	614	1,035	1,030	1,062	1,204	1,226
Long Term Debt	499	422	377	313	217	122	218	451	484	128	212	403	383	283	161
Total Non-Current Liabilities	561	473	457	364	248	160	274	516	533	187	297	499	449	367	249
Total Liabilities	973	958	1,053	896	836	712	727	1,224	1,339	801	1,331	1,529	1,511	1,570	1,476
Total Shareholders' Equity	476	502	518	552	631	718	871	1,004	1,209	1,173	1,466	1,669	1,528	1,515	1,545
Minority Interest	57	80	92	94	126	155	221	149	189	-	-	-	-	-	-
Total Equity	533	582	610	646	758	873	1,092	1,153	1,398	1,173	1,466	1,669	1,528	1,515	1,545
Total Liabilities & Equity	1,505	1,540	1,663	1,542	1,594	1,585	1,818	2,377	2,737	1,974	2,798	3,198	3,039	3,085	3,021

Cash Flow

Abridged

Understanding Cash Flow Statement

Meghmani Organics Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	R 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	98	114	113	112	191	222	365	430	343	242	320	311	-41	110	133
Working Capital - Increase/(Decrease)	-36	22	-56	65	-52	-12	3	-104	14	85	-261	-130	245	-113	9
Net CF from Operating Activities	62	136	56	177	139	210	369	326	356	327	59	180	204	-3	143
Capital Expenditures - Net	87	108	75	46	93	70	241	376	490	209	242	464	264	86	44
Net CF from Investing Activities	-78	-97	-51	-62	-76	-98	-279	-295	-491	-310	-138	-436	-195	20	-46
Dividends Paid - Cash - Total	10	3	3	23	8	-	10	30	42	-	35	36	36	-	-
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	15	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	26	-57	27	-106	-60	-112	-75	334	52	-5	104	312	12	-11	-104
Net Cash Flow from Financing Activities	24	-60	24	-134	-69	-112	-88	98	10	-5	69	276	-23	-11	-104
Free Cash Flow to Equity	1	-29	8	25	-14	27	52	284	-82	113	-79	28	-48	-100	-5
Free Operating CF net dividend	-57	25	-24	94	37	139	113	-82	-177	118	-220	-320	-98	-92	97
Free Operating CF	-47	27	-22	117	45	139	123	-52	-135	118	-184	-285	-62	-92	97

Business Segment Analysis

FY End:

Mar 26

Meghmani Organics Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Agro Chemicals (61.3%)₹ 31.17 CrPigments (25.2%)₹ 12.83 CrOther (6.0%)₹ 3.05 CrEliminations (6.0%)₹ -3.03 CrUnallocated (1.5%)₹ 0.76 Cr

Revenue / Sales

Agro Chemicals (73.1%)₹ 1,631.24 CrPigments (23.8%)₹ 531.36 CrOther (3.1%)₹ 68.28 Cr

Assets

Agro Chemicals (58.5%)₹ 1,815.37 CrPigments (35.0%)₹ 1,085.42 CrOther (6.5%)₹ 202.96 Cr

Regional Segment Analysis

FY End:

Mar 26

Meghmani Organics Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Outside India. (82.6%)₹ 1,795.05 CrWithin India (17.4%)₹ 378.90 Cr

Assets

Within India (100.0%)₹ 1,654.30 CrOutside India. (0.0%)₹ 0.39 Cr

Historical Segment Analysis

Track how Meghmani Organics Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Agro Chemicals	47	104	69	19	18	16	12	52	115	191	215	283	24	20	31
Pigments	12	14	58	16	34	21	29	23	16	25	25	220	175	62	13
Other	5	22	9	2	0	2	7	1	11	0	0	0	54	14	3
Unallocated	-	-	-	-	-	-	-	-	-	0	1	0	0	0	1
Chloro Alkali and Its Derivatives	492	16	61	8	22	59	23	391	413	-	-	-	-	-	-
Eliminations	-4	1	-10	0	0	0	0	0	0	0	0	0	-5	1	-3

Frequently Asked Questions

What is the revenue of Meghmani Organics Ltd.?

The latest trailing twelve month revenue of Meghmani Organics Ltd. is ₹ 2,103.16 Cr, reflecting a 1-year growth of -7.74% and a 3-year CAGR of -1.41%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Meghmani Organics Ltd.?

The latest trailing twelve month net profit (PAT) of Meghmani Organics Ltd. is ₹ 64.26 Cr, with a 3-year earnings CAGR of -50.55%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Meghmani Organics Ltd.?

The trailing twelve month EBITDA of Meghmani Organics Ltd. is approximately ₹ 55.62 Cr (based on an operating margin of 2.64%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Meghmani Organics Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Meghmani Organics Ltd. is 1.13. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Meghmani Organics Ltd.?

The debt-to-equity ratio of Meghmani Organics Ltd. stands at 0.47. The interest coverage ratio is 1.17x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Meghmani Organics Ltd.?

The estimated book value per share of Meghmani Organics Ltd. is 60.74 (derived from a P/B ratio of 1.03 and market price of ₹ 62.51), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Meghmani Organics Ltd.?

The trailing twelve month operating cash flow of Meghmani Organics Ltd. is ₹ 142.55 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Meghmani Organics Ltd. report consolidated or standalone financials?

Meghmani Organics Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.